About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 93 record(s)
Req # A-2016-001921
All records as it pertains to Natural Product Number (NPN) 80043184 (Dove Cleartone)Organization: Health Canada
July 2022
Req # A-2017-001094
All documents from October 1, 2017 to November 16, 2017 that mention a tax on sugar or fat, a fat tax, a sugar tax, a sugar-sweetened beverage tax (SSB tax), soft drink tax, soda tax, or junk food taxOrganization: Health Canada
July 2022
Req # A-2018-000383
All reviewers' reports regarding the cleared Supplement to a New Drug Submission (SNDS) for the pre-filled syringe presentation.Organization: Health Canada
July 2022
Req # A-2018-000999
All correspondence sent by Health Canada to Teva Pharmaceuticals USA between January 1, 1996 to January 1, 1998, with respect to the new drug submission for glatiramer acetate (tradename: COPAXONE, NDS 044430, rec. 1996-07-12), Notice of Compliance date 1997-09-04.Organization: Health Canada
July 2022
Req # A-2019-000581
Any correspondence between Johnson and Johnson and Health Canada related to vapour products, vaping products, electronic cigarettes and electronic nicotine delivery systems, from January 1, 2017 to July 18, 2019.Organization: Health Canada
July 2022
Req # A-2020-000269
The most current Canadian Risk Management Plan (RMP) and any additional pharmacovigilance activities/risk minimization actions in Canada for TREANDA.Organization: Health Canada
July 2022
Req # A-2020-000958
Information regarding Waterite Inc. (NEQ: 1171855852) (hereinafter the "Company"). Any document concerning the Company and the building located at: Address of the building: 1850 Beaulac Saint-Laurent, QC H4R 2E7 Lot: 1 164 332 Land Register of Quebec, Registration Division of Montreal Owner: Les Immeubles Thimens Corp.Organization: Health Canada
July 2022
Req # A-2020-000974
All records submitted by the manufacturers to Health Canada for the following test kits: COVID-19 Quantitative Polymerase Chain Reaction (QPCR) Multi Kit, Abbott Realtime SARS-COV-2 Assay, Aries SARS-CoV-2 Assay, PerkinElmer New Coronavirus Nucleic Acid Detection Kit.Organization: Health Canada
July 2022
Req # A-2020-001917
All records within Health Canada's possession or control in relation to SONA's application for the approval of its rapid antigen COVID-19 test.Organization: Health Canada
July 2022
Req # A-2020-001930
All adverse event/incident reports for all of the device components under the M2a, M2a Magnum and ReCap Femoral Resurfacing System.Organization: Health Canada
July 2022